Last reviewed · How we verify
PRV-015
At a glance
| Generic name | PRV-015 |
|---|---|
| Sponsor | Provention Bio, a Sanofi Company |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- PRV-015 in Gluten-free Diet Non-responsive Celiac Disease (PHASE2)
- A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRV-015 CI brief — competitive landscape report
- PRV-015 updates RSS · CI watch RSS
- Provention Bio, a Sanofi Company portfolio CI